ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Binbin Zheng-Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2478-8299; OpenAlex author ID A5040249834. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

The Differential Impact of Neoadjuvant Therapies on the Tumor Microenvironment, Peripheral Biomarkers, and Survival in Pancreatic Cancer: A Retrospective Cohor… Co-author DOI 10.3390/cancers18101567 ↗
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s40291-022-00614-1 ↗
Pancreatic ductal adenocarcinoma in the era of precision medicine. Co-author DOI 10.1053/j.seminoncol.2021.01.005 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Eileen Mary O'Reilly · 2 shared papers, 2021–2022 · strength 0.40
- Paper Pancreatic ductal adenocarcinoma in the era of precision medicine. DOI 10.1053/j.seminoncol.2021.01.005 ↗
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Kristina Hoot Young · 1 shared paper, 2026 · strength 0.33
- Paper The Differential Impact of Neoadjuvant Therapies on the Tumor Microenvironment, Peripheral Biomarkers, and Survival in … DOI 10.3390/cancers18101567 ↗
Trevor Silva · 1 shared paper, 2026 · strength 0.33
- Paper The Differential Impact of Neoadjuvant Therapies on the Tumor Microenvironment, Peripheral Biomarkers, and Survival in … DOI 10.3390/cancers18101567 ↗
Marinela Capanu · 1 shared paper, 2022 · strength 0.12
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Michael Rainone · 1 shared paper, 2022 · strength 0.12
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Anna M. Varghese · 1 shared paper, 2022 · strength 0.12
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Zsofia Kinga Stadler · 1 shared paper, 2022 · strength 0.12
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Wungki Park · 1 shared paper, 2022 · strength 0.12
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗
Kenneth H. Yu · 1 shared paper, 2022 · strength 0.12
- Paper Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Panc… DOI 10.1007/s40291-022-00614-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.